Outcomes and Associated Factors after Melphalan 140 Mg/m² Autologous Hematopoietic Cell Transplantation for Multiple Myeloma in Patients over 70 Years of Age
20260 citationsJournal Article
Field-Weighted Citation Impact: 0.00
Outcomes and Associated Factors after Melphalan 140 Mg/m² Autologous Hematopoietic Cell Transplantation for Multiple Myeloma in Patients over 70 Years of Age | Researchclopedia